IP Library Granted Patent US 11,891,657
Granted Patent B2
US 11,891,657 · App. 17/093,429 · Granted Feb 6, 2024

Ultra-sensitive platform for nucleic acid detection using a novel method, scanning digital polymerase chain reaction (PCR)

Inventors: Harold E. Ayliffe (Ketchum, ID); Donald O'Neil (Ketchum, ID)
Assignee: Orflo Technologies LLC
C12Q1/686C12Q1/6827C12Q1/6848
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,891,657
App. No.
17/093,429
Granted
Feb 6, 2024
Kind
B2
Abstract

A method for analyzing a target nucleic acid includes diluting nucleic acid targets and filling pico to femto-liter sized wells such that they contain a single target nucleic acid and one or more amplification reagents, amplifying the target in the individual wells, distinguishing wells containing amplicon from the target and amplicon from a variant of the target generated by polymerase error by using two differently labeled-hybridization probes, one hybridizing to the target and one hybridizing to a specific variant of the target; and analyzing target amplicons.

Claims (8)

1. A system for detecting a target nucleic acid, comprising:

a cassette, the cassette comprising a sample input configured to receive an emulsion containing at least one target molecule and at least one non-target molecule, the cassette further comprising at least one intermediate layer, the cassette further comprising at least one capping layer, the at least one capping layer and intermediate layer defining at least one chamber, the at least one intermediate layer having a droplet orifice formed therethrough allowing fluid communication between the sample input and a first chamber of the at least one chamber, the at least one intermediate layer defining at least one egress orifice allowing the emulsion to exit the at least one chamber; and

a flow cytometer having an interior configured to receive at least a portion of the cassette, the flow cytometer configured to identify the at least one target molecule.

2. The system of claim 1 , wherein the droplet orifice is sized to pass the emulsion molecules from the sample input to the chamber in single file.

3. The system of claim 1 , wherein the flow cytometer identifies the at least one target molecule by scanning molecules of the emulsion with a laser.

4. The system of claim 1 , wherein the egress orifice is part of a Coulter-style particle interrogation structure that interrogates each molecule of the emulsion passing through the egress orifice.

5. The system of claim 1 , further comprising a pressure generator configured to create emulsion droplets by drawing the emulsion molecules from the sample input through the egress orifice.

6. The system of claim 1 , wherein the cassette further comprises a piezoelectric transducer configured to cause only the identified at least one target molecule to be drawn through the droplet orifice.

Assignments (2)
SECURITY INTEREST Recorded Oct 15, 2021
From: GEMINI BIOPRODUCTS, LLC; GEMINI BIOPRODUCTS HOLDING, INC.; ORFLO TECHNOLOGIES, LLC
To: BROADOAK FUND V, L.P. , AS AGENT
Reel/Frame 057806/0220 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 11, 2020
From: HAROLD E. AYLIFFE; O'NEIL, DONALD
To: E.I. SPECTRA, LLC
Reel/Frame 054336/0322 →
Continuity (3)
Continuation 16184863 · Nov 8, 2018
Provisional Application 62584055 · Nov 9, 2017
Related Publication 20210054441A1 · Feb 25, 2021